Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000043459
- Lead Sponsor
- Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia
- Brief Summary
MWH administration was associated with a lower in-hospital mortality, and 28/30-day mortality compared with UFH administration. However, there was no difference in the incidence of bleeding with LMWH compared with UFH.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2506
Inclusion Criteria
Not provided
Exclusion Criteria
missing required data, no data on anticoagulant use, no outcome of interest, other than english language
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method